NewEdge Advisors’s Ocean Bio-Chem Inc OBCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,047
| Closed | -$181K | – | 1690 |
|
|
2022
Q2 | $181K | Hold |
14,047
| – | – | ﹤0.01% | 1407 |
|
|
2022
Q1 | $115K | Hold |
14,047
| – | – | ﹤0.01% | 1076 |
|
|
2021
Q4 | $122K | Sell |
14,047
-884
| -6% | -$8.65K | ﹤0.01% | 1575 |
|
|
2021
Q3 | $141K | Hold |
14,931
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q2 | $182K | Sell |
14,931
-1,119
| -7% | -$14.3K | ﹤0.01% | 1063 |
|
|
2021
Q1 | $193K | Hold |
16,050
| – | – | 0.01% | 951 |
|
|
2020
Q4 | $214K | Sell |
16,050
-892
| -5% | -$12.8K | 0.01% | 876 |
|
|
2020
Q3 | $243K | Sell |
16,942
-1,776
| -9% | -$26.9K | 0.01% | 774 |
|
|
2020
Q2 | $261K | Buy |
18,718
+2,668
| +17% | +$17.8K | 0.01% | 709 |
|
|
2020
Q1 | $78K | Hold |
16,050
| – | – | ﹤0.01% | 753 |
|
|
2019
Q4 | $53K | Hold |
16,050
| – | – | ﹤0.01% | 801 |
|
|
2019
Q3 | $56K | Buy |
+16,050
| New | +$55.1K | ﹤0.01% | 794 |
|
NewEdge Advisors's OBCI Position: Q3 2022 in Review
NewEdge Advisors sold out of Ocean Bio-Chem Inc (OBCI) in Q3 2022, closing a stake of 14,047 shares — an estimated $181K sold.
NewEdge Advisors first reported a position in OBCI in Q3 2019 and held it in 12 quarters. The position peaked at $261K in Q2 2020. 0 funds tracked by Wall St. Rank hold OBCI as of Q3 2022.
- NewEdge Advisors reported no remaining Ocean Bio-Chem Inc position as of Q3 2022 after selling out during the quarter.
- NewEdge Advisors sold 14,047 Ocean Bio-Chem Inc shares in Q3 2022, an estimated $181K.
- NewEdge Advisors first reported a position in Ocean Bio-Chem Inc in Q3 2019 and held it in 12 quarters.
- NewEdge Advisors's Ocean Bio-Chem Inc position peaked at $261K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q3 2022.
Based on NewEdge Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.